RG
Rishi Ganju
About Rishi Ganju
Data last updated:
Rishi Ganju is a Director at Atrimed Pharmaceuticals Private Limited (since 2021). The company operates in Healthcare. Atrimed Pharmaceuticals Private Limited reported revenue of ₹24.09 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Atrimed Pharmaceuticals Private Limited U02423KA2003PTC032200 | Director | 09 Sep 2021 | 2003 | ₹24.09 Cr (FY 2024) | Active |
Board colleagues of Rishi Ganju
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ganju Shibban Krishen | 01966923 | Atrimed Pharmaceuticals Private Limited | Director |
| Hrishikesh Damle | 00574119 | Atrimed Pharmaceuticals Private Limited | Director |
| Latha Damle | 07038353 | Atrimed Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rishi Ganju
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rishi Ganju
Rishi Ganju currently holds 1 directorship: Atrimed Pharmaceuticals Private Limited (Director, since 09 Sep 2021, revenue ₹24.09 Cr (FY 2024)).
Rishi Ganju was first appointed on 09 Sep 2021 as Director at Atrimed Pharmaceuticals Private Limited.
The current boards of Rishi Ganju's companies include Ganju Shibban Krishen (Atrimed Pharmaceuticals Private Limited), Hrishikesh Damle (Atrimed Pharmaceuticals Private Limited), Latha Damle (Atrimed Pharmaceuticals Private Limited).